Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Testing of experimental compounds in a relapse model of tuberculosis using granulocyte-macrophage colony-stimulating factor gene-disrupted mice.

Woolhiser LK, Hoff DR, Marietta KS, Orme IM, Lenaerts AJ.

Antimicrob Agents Chemother. 2009 Jan;53(1):306-8. doi: 10.1128/AAC.01346-07. Epub 2008 Oct 13.

2.

Evaluation of a 2-pyridone, KRQ-10018, against Mycobacterium tuberculosis in vitro and in vivo.

Lenaerts AJ, Bitting C, Woolhiser L, Gruppo V, Marietta KS, Johnson CM, Orme IM.

Antimicrob Agents Chemother. 2008 Apr;52(4):1513-5. doi: 10.1128/AAC.00897-07. Epub 2008 Feb 11.

3.

Rapid microbiologic and pharmacologic evaluation of experimental compounds against Mycobacterium tuberculosis.

Gruppo V, Johnson CM, Marietta KS, Scherman H, Zink EE, Crick DC, Adams LB, Orme IM, Lenaerts AJ.

Antimicrob Agents Chemother. 2006 Apr;50(4):1245-50.

4.

Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models.

Lenaerts AJ, Gruppo V, Marietta KS, Johnson CM, Driscoll DK, Tompkins NM, Rose JD, Reynolds RC, Orme IM.

Antimicrob Agents Chemother. 2005 Jun;49(6):2294-301.

Supplemental Content

Loading ...
Support Center